Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters

Affiliations

• ¹ Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, United Kingdom. Electronic address: alessiocortellini@gmail.com.
• ² Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, Villejuif, France.
• ³ ClinicObiome, Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France; Institut National de la Santé et de la recherche médicale (INSERM) U1015, Villejuif, France.
• ⁴ Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.